SCHEMBL22911682

SCHEMBL22911682

C[C@H](COC(N)=O)Cc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.54
CYP1A2 P05177 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
CYP2D6 P10635 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
LMNA P02545 2/20 0.49
SRR Q9GZT4 2/20 0.46
EPHX1 P07099 1/20 0.46
ALPI P09923 1/20 0.46
PTGS1 P23219 1/20 0.46
XIAP P98170 1/20 0.46
SLC7A5 Q01650 1/20 0.46
SLC6A2 P23975 2/20 0.46
TAAR1 Q96RJ0 2/20 0.46
MAOA P21397 1/20 0.46
SLC6A4 P31645 1/20 0.46
SLC6A3 Q01959 1/20 0.46
SIGMAR1 Q99720 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7292748 1.00 PKM (0.54) PKMCYP1A2SMN1; SMN2CYP2D6NPSR1
SCHEMBL5622799 0.86 NPC1 (0.53) CYP1A2NPC1RAB9ALMNASLC6A2
SCHEMBL16137501 0.84 ALDH1A1 (0.56) PKMCYP1A2NPC1RAB9ALMNA
SCHEMBL15247513 0.84 ALDH1A1 (0.56) PKMCYP1A2NPC1RAB9ALMNA
SCHEMBL10886546 0.84 ALDH1A1 (0.56) PKMCYP1A2NPC1RAB9ALMNA
SCHEMBL24073103 0.84 NPC1 (0.51) CYP1A2NPC1RAB9ALMNASRR
SCHEMBL9049029 0.83 CYP1A2 (0.56) PKMCYP1A2SMN1; SMN2CYP2D6NPSR1
SCHEMBL7260000 0.83 CYP3A4 (0.50) CYP1A2NPC1RAB9ALMNAALDH1A1
SCHEMBL7292741 0.83 NPC1 (0.50) CYP1A2NPC1RAB9ALMNASRR
SCHEMBL8926076 0.81 NPC1 (0.49) CYP1A2NPC1RAB9ALMNASRR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021158899-A1 ELONGATION FACTOR 1-ALPHA INHIBITORS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-08-12 WO disclosed
WO-2021011723-A1 ANTI-OSTEOARTHRITIS HYDANTOIN COMPOUNDS AND RELATED COMPOSITIONS AND METHODS AVIDENCE THERAPEUTICS, INC. (US) 2021-01-21 WO disclosed